TITLE

Genetically Confirmed Neonatal Diabetes: A Single Centre Experience

AUTHOR(S)
Dalvi, Nazia; Shaikh, Shareque; Shivane, Vyankatesh; Lila, Anurag; Bandgar, Tushar; Shah, Nalini; Dalvi, Nazia Nazir Hussain; Shaikh, Shareque T; Shivane, Vyankatesh K; Lila, Anurag R; Bandgar, Tushar R; Shah, Nalini S
PUB. DATE
January 2017
SOURCE
Indian Journal of Pediatrics;Jan2017, Vol. 84 Issue 1, p86
SOURCE TYPE
Academic Journal
DOC. TYPE
letter
ABSTRACT
No abstract available.
ACCESSION #
120497380

 

Related Articles

  • Patient With iDEND Syndrome--Related Mutation. Prado-Carro, Ana M.; Calzada-Hernández, Joan; Marín, Silvia; Cardona-Hernandez, Roque; Oriola, Josep; Nicolás, Marta; Ramon-Krauel, Marta // Diabetes Care;Jun2014, Vol. 37 Issue 6, pe123 

    The article focuses on the improvement of metabolic control and neurologic outcome for neonatal patients based on the result of genetic confirmation of a sulfonylurea-responsive form of diabetes. Topics include the role of mutations on the ATP-sensitive K+ (KATP) in diabetes, the effect of...

  • Outcome of infants with prenatally diagnosed congenital heart disease delivered outside specialist paediatric cardiac centres. Anagnostou, Katherine; Messenger, Lisa; Yates, Robert; Kelsall, Wilf // Archives of Disease in Childhood -- Fetal & Neonatal Edition;May2013, Vol. 98 Issue 3, pF218 

    Objective To determine the outcome of neonates with a suspected antenatal diagnosis of congenital heart disease (CHD) who were delivered away from a paediatric cardiothoracic centre and were initially managed in a level 3 Neonatal Intensive Care Unit. Methods An 18-year ongoing study conducted...

  • P03 The use of BRUM1 resequencing microarray to identify mutations in patients with neonatal cholestasis. Hartley, J; Bruce, C; Brown, R; McKay, K; Bauman, U; Sturm, E; Udd, B; Mckiernan, P; McMullen, D; Mansson, J; McDonald, F; Maher, E; Knisely, A; Hendriksz, C; Kelly, D; Gissen, P // Gut;Sep2010 Supp, Vol. 59, pA12 

    Introduction Neonatal cholestasis is the presenting clinical feature of serious and potentially life limiting liver diseases such as progressive familial intrahepatic cholestasis (PFIC), arthrogryposis-renal-cholestasis (ARC) syndrome and Niemann Pick C (NPC) disease. A single rapid molecular...

  • Neonatal Diabetes With End-Stage Nephropathy. Esmatjes, Enric; Jimenez, Amanda; Diaz, Gonzalo; Mora, Mireia; Casamitjana, Roser; De Nanclares, G. Pérez; Castaño, Luis; Ricart, Maria José // Diabetes Care;Nov2008, Vol. 31 Issue 11, p2116 

    OBJECTIVE -- To describe the diagnosis of a patient with neonatal diabetes who had been misdiagnosed with type 1 diabetes and referred to our hospital for pancreas and kidney transplantation because of end-stage renal disease. RESEARCH DESIGN AND METHODS -- A diagnosis of neonatal diabetes was...

  • Analysis of clinical and genetic features among 12 neonatal diabetes mellitus. Cao Bingyan; Gong Chunxiu; Yang Jinkui; Cao Xi; Wu Di // International Journal of Pediatric Endocrinology;2013, Vol. 2013 Issue Suppl 1, p1 

    An abstract of the study "Analysis of Clinical and Genetic Features Among 12 Neonatal Diabetes Mellitus" by Cao Bingyan et al is presented.

  • Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes. Marquis, E.; Robert, J. J.; Bouvattier, C.; Bellanné-Chantelot, C.; Junien, C.; Diatloff-Zito, C. // Journal of Medical Genetics;May2002, Vol. 39 Issue 5, p370 

    Examines differences in developmental and phenotypic abnormalities between transient and permanent neonatal diabetes. Molecular genetic studies of patients with transient or permanent neonatal diabetes; Dinucleotide repeat marker analysis for chromosome 6; Congenital abnormalities in patients...

  • Is there a genetic basis for gestational diabetes? Lucarini, Nazzareno; Gerlini, Gianfranco // Human Biology;Aug94, Vol. 66 Issue 4, p715 

    Studies the possibility of a genetic basis for gestational diabetes. Risk of fetal and neonatal complications; Relationship between Rh blood system and diabetes mellitus; Factors affecting susceptibility to diabetes.

  • Sulfonylurea Use During Entire pregnancy in Diabetes Because of KCNJ1 1 Mutation: A Report of Two Cases. Gaal, Zsolt; Klupa, Tomasz; Kantor, Irene; Mlynarski, Wojciech; Albert, Laszlo; Tolloczko, Justyna; Balogh, Istvan; Czajkowski, Krzysztof; Malecki, Maciej T. // Diabetes Care;Jun2012, Vol. 35 Issue 6, pe40 

    The article reports on two cases of sulfonylurea (SU) use during entire pregnancy in diabetes because of KCNJ11 mutation. The first patient was a Hungarian woman who had experience remission at which point insulin was restarted due to her relapsing neonatal diabetes. Her genetic testing from the...

  • Transgenic rescue of insulin receptor--deficient mice. Okamoto, Haruka; Nakae, Jun; Kitamura, Tadahiro; Park, Byung-Chul; Dragatsis, Loannis; Accili, Domenico // Journal of Clinical Investigation;Jul2004, Vol. 114 Issue 2, p214 

    The role of different tissues in insulin action and their contribution to the pathogenesis of diabetes remain unclear. To examine this question, we have used genetic reconstitution experiments in mice. Genetic ablation of insulin receptors causes early postnatal death from diabetic ketoacidosis....

  • Cost-utility analysis of genetic testing in neonatal diabetes.  // Diabetes Digest;2011, Vol. 10 Issue 3, p141 

    The article discusses a cost-utility analysis by S. A. Greeley and colleagues on routine genetic screening in children with permanent neonatal diabetes (ND).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics